ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions (TAMARIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00566657
Recruitment Status : Completed
First Posted : December 3, 2007
Last Update Posted : May 2, 2016
Sponsor:
Information provided by (Responsible Party):
Sanofi